PMC:7441788 / 18683-19228 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T182","span":{"begin":137,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T231","span":{"begin":44,"end":49},"obj":"Chemical"},{"id":"T232","span":{"begin":67,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A231","pred":"chebi_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A232","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T11","span":{"begin":391,"end":400},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A11","pred":"meddra_id","subj":"T11","obj":"http://purl.bioontology.org/ontology/MEDDRA/10047890"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T139","span":{"begin":0,"end":19},"obj":"Sentence"},{"id":"T140","span":{"begin":20,"end":263},"obj":"Sentence"},{"id":"T141","span":{"begin":264,"end":435},"obj":"Sentence"},{"id":"T142","span":{"begin":436,"end":545},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"676","span":{"begin":40,"end":43},"obj":"Chemical"},{"id":"677","span":{"begin":63,"end":66},"obj":"Chemical"},{"id":"678","span":{"begin":82,"end":85},"obj":"Chemical"},{"id":"679","span":{"begin":182,"end":185},"obj":"Chemical"},{"id":"712","span":{"begin":244,"end":249},"obj":"Disease"}],"attributes":[{"id":"A676","pred":"pubann:denotes","subj":"676","obj":"MESH:D006886"},{"id":"A677","pred":"pubann:denotes","subj":"677","obj":"MESH:D006886"},{"id":"A678","pred":"pubann:denotes","subj":"678","obj":"MESH:D006886"},{"id":"A679","pred":"pubann:denotes","subj":"679","obj":"MESH:D006886"},{"id":"A712","pred":"pubann:denotes","subj":"712","obj":"MESH:D003643"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T65","span":{"begin":244,"end":249},"obj":"http://purl.obolibrary.org/obo/GO_0016265"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-PubTator","denotations":[{"id":"676","span":{"begin":40,"end":43},"obj":"Chemical"},{"id":"677","span":{"begin":63,"end":66},"obj":"Chemical"},{"id":"678","span":{"begin":82,"end":85},"obj":"Chemical"},{"id":"679","span":{"begin":182,"end":185},"obj":"Chemical"},{"id":"712","span":{"begin":244,"end":249},"obj":"Disease"}],"attributes":[{"id":"A676","pred":"tao:has_database_id","subj":"676","obj":"MESH:D006886"},{"id":"A677","pred":"tao:has_database_id","subj":"677","obj":"MESH:D006886"},{"id":"A678","pred":"tao:has_database_id","subj":"678","obj":"MESH:D006886"},{"id":"A679","pred":"tao:has_database_id","subj":"679","obj":"MESH:D006886"},{"id":"A712","pred":"tao:has_database_id","subj":"712","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}

{"project":"LitCovid-sentences","denotations":[{"id":"T139","span":{"begin":0,"end":19},"obj":"Sentence"},{"id":"T140","span":{"begin":20,"end":263},"obj":"Sentence"},{"id":"T141","span":{"begin":264,"end":435},"obj":"Sentence"},{"id":"T142","span":{"begin":436,"end":545},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Geleris et al [55]. Observational study HCQ group: n = 811; no-HCQ group: n = 565 HCQ (600 mg/2 times on the first day, then 400 mg once a day for 4 days) No correlation between the HCQ use and significant higher or lower risk of intubation or death was observed. Large sample size; Minimization of the unmeasured confusion and error through multivariable Cox model with inverse probability weighting according to the propensity score. Single-center design; missing of some variables; Potential for inaccuracies in the electronic health records."}